000276485 001__ 276485
000276485 005__ 20250323000828.0
000276485 0247_ $$2doi$$a10.1016/j.bpsgos.2024.100431
000276485 0247_ $$2altmetric$$aaltmetric:173938196
000276485 0247_ $$2pmid$$apmid:39990626
000276485 037__ $$aDZNE-2025-00302
000276485 082__ $$a610
000276485 1001_ $$0P:(DE-2719)9001827$$aLiebscher, Maxie$$b0$$eFirst author
000276485 245__ $$aCirculating Stress Hormones, Brain Health, and Cognition in Healthy Older Adults: Cross-Sectional Findings and Sex Differences in Age-Well
000276485 260__ $$aAmsterdam$$bElsevier$$c2025
000276485 3367_ $$2DRIVER$$aarticle
000276485 3367_ $$2DataCite$$aOutput Types/Journal article
000276485 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1739194650_14836
000276485 3367_ $$2BibTeX$$aARTICLE
000276485 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000276485 3367_ $$00$$2EndNote$$aJournal Article
000276485 520__ $$aBackground: Increased stress is a proposed risk factor for Alzheimer’s disease (AD). We examined cross-sectional associations between circulating stress biomarkers and multimodal measures of brain health and cognition susceptible to AD in older adults and sex-specific subgroups.Methods: Baseline data from 132 cognitively unimpaired participants without depression (age, mean ± SD = 74.0 ± 4.0 years, women: n = 80) in the Age-Well trial (NCT02977819) were included. Stress hormone levels were measured in overnight fasting blood serum (cortisol, dehydroepiandrosterone sulfate) and blood plasma (epinephrine, norepinephrine) samples. AD-sensitive measures of brain health, including glucose metabolism (n = 89), cerebral perfusion, gray matter volume, amyloid deposition in a priori regions of interest, and cognitive markers were evaluated. Models were adjusted for age, sex, education, trait anxiety, and depressive symptoms.Results: Higher epinephrine levels were associated (false discovery rate–corrected p < .05) with lower glucose metabolism in the anterior cingulate cortex (β = −0.26, p = .008), posterior cingulate cortex (β = −0.32, p = .006), and precuneus (β = −0.27, p = .021) and lower perfusion in the posterior cingulate cortex (β = −0.23, p = .013). Interactions between stress hormones and sex showed (false discovery rate–corrected p < .05) that in women only, higher epinephrine was associated with larger anterior cingulate cortex volume (interaction: β = 0.32, p = .016), whereas in men only, higher cortisol was associated with lower episodic memory performance (interaction: β = 0.98, p = .012).Conclusions: The current study demonstrates the involvement of circulating stress hormones, particularly epinephrine and cortisol, in greater resilience or vulnerability of brain health and cognitive indicators of susceptibility to AD in older adults. The identification of sex-specific patterns in these associations may inform the development of more effective and tailored interventions.
000276485 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000276485 588__ $$aDataset connected to CrossRef, Journals: pub.dzne.de
000276485 7001_ $$0P:(DE-2719)2810508$$aWhite, Silke$$b1$$eFirst author
000276485 7001_ $$0P:(DE-2719)9002359$$aHass, Simon$$b2
000276485 7001_ $$aChocat, Anne$$b3
000276485 7001_ $$aMezenge, Florence$$b4
000276485 7001_ $$aLandeau, Brigitte$$b5
000276485 7001_ $$aDelarue, Marion$$b6
000276485 7001_ $$aHébert, Oriane$$b7
000276485 7001_ $$aTurpin, Anne-Laure$$b8
000276485 7001_ $$aMarchant, Natalie L.$$b9
000276485 7001_ $$aChételat, Gaël$$b10
000276485 7001_ $$0P:(DE-2719)9002456$$aKlimecki-Lenz, Olga Maria$$b11$$udzne
000276485 7001_ $$0P:(DE-HGF)0$$aPoisnel, Géraldine$$b12
000276485 7001_ $$0P:(DE-2719)2814122$$aWirth, Miranka$$b13$$eLast author
000276485 773__ $$0PERI:(DE-600)3094992-0$$a10.1016/j.bpsgos.2024.100431$$gVol. 5, no. 2, p. 100431 -$$n2$$p100431$$tBiological psychiatry: global open science$$v5$$x2667-1743$$y2025
000276485 8564_ $$uhttps://pub.dzne.de/record/276485/files/DZNE-2025-00302.pdf$$yOpenAccess
000276485 8564_ $$uhttps://pub.dzne.de/record/276485/files/DZNE-2025-00302.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000276485 909CO $$ooai:pub.dzne.de:276485$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000276485 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001827$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000276485 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810508$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000276485 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002359$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000276485 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9002456$$aExternal Institute$$b11$$kExtern
000276485 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2814122$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b13$$kDZNE
000276485 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000276485 9141_ $$y2025
000276485 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-28
000276485 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-28
000276485 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-28
000276485 915__ $$0LIC:(DE-HGF)CCBYNCND4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
000276485 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2024-12-28
000276485 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2022-11-10T08:42:22Z
000276485 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2022-11-10T08:42:22Z
000276485 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-28
000276485 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-28
000276485 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000276485 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2022-11-10T08:42:22Z
000276485 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-28
000276485 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-28
000276485 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-28
000276485 920__ $$lyes
000276485 9201_ $$0I:(DE-2719)1710011$$kAG Wirth$$lBrain Resilience$$x0
000276485 980__ $$ajournal
000276485 980__ $$aVDB
000276485 980__ $$aUNRESTRICTED
000276485 980__ $$aI:(DE-2719)1710011
000276485 9801_ $$aFullTexts